Maltese are second-highest EU spenders on medicines
Malta stands out within the European Union for its unusually high spending on retail pharmaceuticals, a pattern that…
Calls by Cavan councillor to scrap planned €50 charge for blister packs
A local councillor has called on the Minister for Health to reverse the decision of the €50 charge…
A Nationwide Recall of 8,500 ADHD Medication Bottles Just Received an Update from the FDA
Though health experts estimate that at least 7 million children in the U.S. have attention-deficit/hyperactivity disorder (ADHD), diagnoses…
How to save money on prescriptions
For patients across the country, filling a prescription can come with tough financial choices. Health researchers at KFF…
How GLP-1s are quietly changing chain restaurant menus
As GLP-1 medications normalize smaller appetites and higher protein intake, national restaurant chains are quietly redesigning their menus…
Ginseng adulteration remains a significant concern
The new publication summarizes information on the authenticity of 910 commercial ginseng products reported in 48 peer-reviewed publications.…
‘It’s not illegal’: How prescription drugs are filling the void left by Kpods
Etomidate was listed as a Class C drug under the Misuse of Drugs Act on Sep 1, 2025,…
How to save money on prescriptions
For patients across the country, filling a prescription can come with tough financial choices. Health researchers at KFF…
FDA issues nationwide recall for a widely-used nasal spray
Federal regulators ordered a nationwide recall after routine testing uncovered live microbes inside a commonly used nasal spray…
Funding Wegovy will save taxpayer money in long run – specialist
Wegovy slimming medication at a pharmacy in Berlin. Photo: AFP / Jens Kalaene Pharmac is seeking clinical advice…
UK halts export of cancer and painkiller drugs as shortages hit pharmacies
Manufacturing delays and poor supply due to Britain offering low prices has hit chemists’ shelves The Government has…
FDA’s new expedited drug program raises legal questions and concerns
WASHINGTON (AP) — The Food and Drug Administration commissioner’s effort to drastically shorten the review of drugs favored by President Donald Trump’s administration is…